| scholarly article | Q13442814 |
| P50 | author | Joanne Lysaght | Q59612574 |
| James J Phelan | Q59632959 | ||
| John V Reynolds | Q37834464 | ||
| Jacintha O'Sullivan | Q39559654 | ||
| P2093 | author name string | Katie E O'Sullivan | |
| Ciara O'Hanlon | |||
| P2860 | cites work | Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population. | Q45989940 |
| Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial | Q46107107 | ||
| Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus | Q47889930 | ||
| Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus. | Q50665061 | ||
| The effects of obesity on oesophageal function, acid exposure and the symptoms of gastro-oesophageal reflux disease. | Q51281719 | ||
| HIF-1alpha protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia. | Q51757402 | ||
| SPARC: a Ca2+-binding extracellular protein associated with endothelial cell injury and proliferation. | Q52247497 | ||
| Chromosomal instability in Barrett's esophagus is related to telomere shortening. | Q53343136 | ||
| Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. | Q53367382 | ||
| Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. | Q53838777 | ||
| Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. | Q54350731 | ||
| IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. | Q54545081 | ||
| Esophageal Cancer | Q56209683 | ||
| Adipose tissue as an endocrine organ | Q57257904 | ||
| Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus | Q57259733 | ||
| Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus | Q57259755 | ||
| Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus | Q57259827 | ||
| Visceral obesity, metabolic syndrome, insulin resistance and cancer | Q57521562 | ||
| Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995 | Q58053717 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development | Q24616554 | ||
| Inflammation and cancer | Q24649640 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Inflammation and cancer: back to Virchow? | Q28036756 | ||
| Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing | Q28131793 | ||
| The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) | Q28139056 | ||
| Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis | Q28194560 | ||
| Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats | Q28346258 | ||
| STATs in cancer inflammation and immunity: a leading role for STAT3 | Q29547203 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Mitochondrial free radical generation, oxidative stress, and aging | Q29614202 | ||
| Requirement for generation of H2O2 for platelet-derived growth factor signal transduction | Q29615245 | ||
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | Q29615455 | ||
| Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB | Q29619314 | ||
| microRNAs as oncogenes and tumor suppressors | Q29619907 | ||
| Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus | Q33617647 | ||
| Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? | Q33921803 | ||
| Chronic inflammation in obesity and the metabolic syndrome | Q34035348 | ||
| MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status | Q34258256 | ||
| The genomic landscape of oesophagogastric junctional adenocarcinoma | Q34389892 | ||
| Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma | Q34393702 | ||
| Is obesity an inflammatory condition? | Q34463786 | ||
| Central adiposity and risk of Barrett's esophagus | Q34660127 | ||
| Tumors and inflammatory infiltrates: friends or foes? | Q34687554 | ||
| Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells | Q34718996 | ||
| Deletion at fragile sites is a common and early event in Barrett's esophagus. | Q35002032 | ||
| Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome | Q35093279 | ||
| HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells | Q35102340 | ||
| Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity | Q35355142 | ||
| Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants | Q35594551 | ||
| Inflammatory gradient in Barrett's oesophagus: implications for disease complications | Q35594952 | ||
| Glutathione and glutathione S-transferases in Barrett's epithelium | Q35977027 | ||
| MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma | Q36101722 | ||
| Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome | Q36120783 | ||
| Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis | Q36205151 | ||
| NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration | Q36291524 | ||
| Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells | Q36309573 | ||
| Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma | Q36322862 | ||
| What aspects of body fat are particularly hazardous and how do we measure them? | Q36336942 | ||
| Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer | Q36612480 | ||
| Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma | Q36623544 | ||
| Reactive oxygen species: a breath of life or death? | Q36731940 | ||
| Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. | Q36841557 | ||
| Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. | Q37042894 | ||
| Insulin resistance--mechanisms, syndromes, and implications | Q37278330 | ||
| Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis | Q37416283 | ||
| In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks | Q37461032 | ||
| Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study | Q37505223 | ||
| Inflammation, microenvironment, and the immune system in cancer progression | Q37515911 | ||
| Inflammation and esophageal carcinogenesis | Q37549612 | ||
| Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. | Q37633568 | ||
| Leptin and gastro-intestinal malignancies | Q37690862 | ||
| Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling | Q37741923 | ||
| Non-Smad signaling pathways | Q37893980 | ||
| Acid reflux and oesophageal cancer | Q37913177 | ||
| Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis | Q37999121 | ||
| Inflammation and Barrett's carcinogenesis | Q38006172 | ||
| Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer | Q38032432 | ||
| The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation | Q38045129 | ||
| Do proton pump inhibitors protect against cancer progression in GERD? | Q38056614 | ||
| Esophagogastric cancer after bariatric surgery: systematic review of the literature | Q38069672 | ||
| Role of endothelial cell metabolism in vessel sprouting. | Q38131224 | ||
| The esophagitis to adenocarcinoma sequence; the role of inflammation | Q38133153 | ||
| Barrett's esophagus: cancer and molecular biology. | Q38151822 | ||
| Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy? | Q38155819 | ||
| Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum | Q39446273 | ||
| Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma | Q39664897 | ||
| Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma | Q39679982 | ||
| Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma. | Q39687487 | ||
| Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model | Q39773312 | ||
| Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells. | Q39997801 | ||
| Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus | Q40417530 | ||
| Telomere length assessment in tissue sections by quantitative FISH: image analysis algorithms. | Q40571150 | ||
| Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. | Q40671403 | ||
| Immunohistochemical study of nuclear factor-kappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkers. | Q40685174 | ||
| The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer | Q41210899 | ||
| Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure | Q41723021 | ||
| Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base | Q42399632 | ||
| Q-FISH analysis of telomere and chromosome instability in the oesophagus with and without squamous cell carcinoma in situ | Q42471233 | ||
| Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats | Q42505743 | ||
| Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK | Q42836024 | ||
| Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation | Q42844623 | ||
| Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3. | Q43068809 | ||
| TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells | Q43071657 | ||
| Effects of bile acids and hydrogen ion on the fine structure of oesophageal epithelium | Q43255325 | ||
| Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis. | Q43535942 | ||
| Oxidative stress has a role in malignant transformation in Barrett's oesophagus | Q44226849 | ||
| Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study | Q44342232 | ||
| Dendritic cells in Barrett's esophagus carcinogenesis: an inadequate microenvironment for antitumor immunity? | Q44407867 | ||
| Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment | Q44450908 | ||
| Genomic instability in patients with Barrett's esophagus | Q44582189 | ||
| The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro | Q44680931 | ||
| Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. | Q44806887 | ||
| p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation | Q45345446 | ||
| Role of aspirin in chemoprevention of esophageal adenocarcinoma: a meta-analysis | Q45830788 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 749-760 | |
| P577 | publication date | 2014-05-23 | |
| P1433 | published in | Expert Review of Gastroenterology & Hepatology | Q15733730 |
| P1476 | title | The role of inflammation in cancer of the esophagus | |
| P478 | volume | 8 |
| Q95488201 | Barrett oesophagus |
| Q60045642 | Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas |
| Q26741429 | Circulating Tumor Cells in the Adenocarcinoma of the Esophagus |
| Q37731640 | Cross-talk among metabolic parameters, esophageal microbiota, and host gene expression following chronic exposure to an obesogenic diet |
| Q41101224 | Diet-related inflammation and oesophageal cancer by histological type: a nationwide case-control study in Sweden |
| Q28391358 | Dietary Inflammatory Index and Risk of Esophageal Squamous Cell Cancer in a Case-Control Study from Iran |
| Q41550236 | Dietary inflammatory index and risk of esophageal squamous cell cancer in a case-control study from Italy. |
| Q87952711 | Dietary inflammatory index and risk of oesophageal cancer in Xinjiang Uyghur Autonomous Region, China |
| Q40177250 | Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study. |
| Q47627791 | Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study |
| Q50892714 | Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma. |
| Q99411864 | Human esophageal myofibroblasts increase squamous epithelial thickness via paracrine mechanisms in an in vitro model of gastroesophageal reflux disease |
| Q64098652 | Interleukin-32: Frenemy in cancer? |
| Q64890638 | Jie Du Tong Ye San Prevents N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis via Inhibition of Inflammation and Proliferation. |
| Q38670580 | Molecular interplay of pro-inflammatory transcription factors and non-coding RNAs in esophageal squamous cell carcinoma |
| Q60049437 | Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma |
| Q38708131 | Potential role of P2X7R in esophageal squamous cell carcinoma proliferation |
| Q53634507 | Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. |
| Q53070030 | The arachidonic acid metabolism protein-protein interaction network and its expression pattern in esophageal diseases. |
Search more.